Private Equity
Flare Capital Partners has promoted Dan Gebremedhin to partner. Gebremedhin joined the healthcare tech-focused venture firm in 2015.
3 min read · 03 January 2019
2 min read · 03 January 2019
Controversy has erupted at August Capital, where the firm has put an end to fundraising for its eighth fund, according to a report from Axios.
1 min read · 02 January 2019
Union Square Ventures has raised $428.8 million for two new funds, including a new core venture capital fund and an opportunity fund, according to filings with the SEC. The firm also is raising an opportunity investors fund.
1 min read · 02 January 2019
Menlo Ventures has set out to raise a $450 million second opportunities fund, according to a filing with the SEC.
1 min read · 02 January 2019
Danville, California-based Northgate Capital has raised $1.2 million for its eighth venture fund, according to an SEC filing. The target is $125 million.
1 min read · 02 January 2019
HJB and MabSpace Biosciences have merged to form Transcenta Holding Ltd, a biotherapeutics company. No financial terms were disclosed. BFC Group Ltd served as financial adviser on the transaction. Dr. Xueming Qian, former founder, chairman and CEO of MabSpace, will serve as CEO of Transcenta while Dr. Jonathan Yining Zhao, co-founder and CEO of HJB, will serve as executive chairman. The backers of HJB and MabSpace include Lilly Asia Ventures, Temasek, Sequoia China, ARCH Venture Partners, Teng Yue Partners and Taikang.
5 min read · 02 January 2019
China-based Antengene Corporation, a clinical stage therapeutics company focused on oncology, has secured $120 million in Series B financing. Boyu Capital and FountainVest led the round with participation from Celgene Corporation, WuXi Corporate Venture Fund, Taikang, Qiming Venture Partners and TF Capital.
1 min read · 02 January 2019
2 min read · 02 January 2019
6 min read · 31 December 2018
